Document:

<PAGE>

                                                                    EXHIBIT 10.6

                                ESCROW AGREEMENT

THIS AGREEMENT made as of the 16th day of December, 2004

BETWEEN:

            CHEMOKINE THERAPEUTICS CORP., a company incorporated under the laws
            of the State of Delaware and having an address 2386 East Mall, Suite
            208, University of British Columbia, Vancouver, British Columbia V6T
            1Z3

            (the "ISSUER")

AND:

            PACIFIC CORPORATE TRUST COMPANY, a trust company duly incorporated
            under the laws of British Columbia having an office at 625 Howe
            Street, 10th Floor, Vancouver, British Columbia, V6C 3B8

            (the "ESCROW AGENT")

AND:

            EACH OF THE UNDERSIGNED SECURITYHOLDERS OF THE ISSUER

            (a "SECURITYHOLDER" or "you")

(collectively, the "PARTIES")

THIS AGREEMENT is being entered into by the Parties under National Policy 46-201
Escrow for Initial Public Offerings (the POLICY) in connection with the proposed
distribution (the IPO), by the Issuer, an established issuer, of common shares
by prospectus, of a minimum of 14,000,000 common share to a maximum of
16,000,000 common shares at a price of CDN$1.00 per common share.

FOR GOOD AND VALUABLE CONSIDERATION, the Parties agree as follows:

                                 PART 1 ESCROW

1.1 APPOINTMENT OF ESCROW AGENT

The Issuer and the Securityholders appoint the Escrow Agent to act as escrow
agent under this Agreement. The Escrow Agent accepts the appointment.

1.2 DEPOSIT OF ESCROW SECURITIES IN ESCROW

(1)   You are depositing the securities (ESCROW SECURITIES) listed opposite your
      name in Schedule "A" with the Escrow Agent to be held in escrow under this
      Agreement. You will immediately deliver or cause to be delivered to the
      Escrow Agent any share

<PAGE>

                                      -2-

      certificates or other evidence of these securities which you have or which
      you may later receive.

(2)   If you receive any other securities (ADDITIONAL ESCROW SECURITIES):

      (a)   as a dividend or other distribution on escrow securities;

      (b)   on the exercise of a right of purchase, conversion or exchange
            attaching to escrow securities, including securities received on
            conversion of special warrants;

      (c)   on a subdivision, or compulsory or automatic conversion or exchange
            of escrow securities; or

      (d)   from a successor issuer in a business combination, if Part 6 of this
            Agreement applies,

      you will deposit them in escrow with the Escrow Agent. You will deliver or
      cause to be delivered to the Escrow Agent any share certificates or other
      evidence of those additional escrow securities. When this Agreement refers
      to escrow securities, it includes additional escrow securities.

(3)   You will immediately deliver to the Escrow Agent any replacement share
      certificates or other evidence of additional escrow securities issued to
      you.

1.3 DIRECTION TO ESCROW AGENT

The Issuer and the Securityholders direct the Escrow Agent to hold the escrow
securities in escrow until they are released from escrow under this Agreement.

                      PART 2 RELEASE OF ESCROW SECURITIES

2.1 RELEASE SCHEDULE FOR AN ESTABLISHED ISSUER

If the Issuer is an ESTABLISHED ISSUER (as defined in section 3.3 of the Policy)
and you have not sold any escrow securities in a permitted secondary offering,
your escrow securities will be released as follows:

<TABLE>
<S>                                                 <C>
On ________, 2___, the date the Issuer's            1/4 of your escrow securities
 securities are listed on a Canadian exchange
(THE LISTING DATE)

6 months after the listing date                     1/3 of your remaining escrow securities

12 months after the listing date                    1/2 of your remaining escrow securities

18 months after the listing date                    your remaining escrow securities
</TABLE>

*In the simplest case, where there are no changes to the escrow securities
initially deposited and no additional escrow securities, then the release
schedule outlined above results in the escrow securities being released in equal
tranches of 25%.

<PAGE>

                                      -3-

If you acquire additional escrow securities, those securities will be added to
the securities already in escrow, to increase the number of remaining escrow
securities. After that, all of the escrow securities will be released in
accordance with the applicable release schedule in the tables above.

2.2 RELEASE SCHEDULE FOR AN EMERGING ISSUER

If the Issuer is an emerging issuer (as defined in section 3.3 of the Policy)
and you have not sold any escrow securities in a permitted secondary offering,
your escrow securities will be released as follows:

<TABLE>
<S>                                                                  <C>
On ________, 2___, the date the Issuer's securities are              1/10 of your escrow securities
listed on a Canadian exchange
(THE LISTING DATE)

6 months after the listing date                                      1/6 of your remaining escrow securities

12 months after the listing date                                     1/5 of your remaining escrow securities

18 months after the listing date                                     1/4 of your remaining escrow securities

24 months after the listing date                                     1/3 of your remaining escrow securities

30 months after the listing date                                     1/2 of your remaining escrow securities

36 months after the listing date                                     your remaining escrow securities
</TABLE>

*In the simplest case, where there are no changes to the escrow securities
initially deposited and no additional escrow securities, the release schedule
outlined above results in the escrow securities being released in equal tranches
of 15% after completion of the release on the listing date

If you acquire additional escrow securities, those securities will be added to
the securities already in escrow, to increase the number of remaining escrow
securities. After that, all of the escrow securities will be released in
accordance with the applicable release schedule in the tables above.

2.3 DELIVERY OF SHARE CERTIFICATES FOR ESCROW SECURITIES

The Escrow Agent will send to each Securityholder any share certificates or
other evidence of that Securityholder's escrow securities in the possession of
the Escrow Agent released from escrow as soon as reasonably practicable after
the release.

2.4 REPLACEMENT CERTIFICATES

If, on the date a Securityholder's escrow securities are to be released, the
Escrow Agent holds a share certificate or other evidence representing more
escrow securities than are to be released, the Escrow Agent will deliver the
share certificate or other evidence to the Issuer or its transfer agent and
request replacement share certificates or other evidence. The Issuer will cause
replacement share certificates or other evidence to be prepared and delivered to
the Escrow Agent. After the Escrow Agent receives the replacement share
certificates or other evidence, the Escrow Agent will send to the Securityholder
or at the Securityholder's direction, the replacement share certificate or other
evidence of the escrow securities released. The Escrow Agent and Issuer will act
as soon as reasonably practicable.

2.5 RELEASE UPON DEATH

<PAGE>
                                      -4-

(1)   If a Securityholder dies, the Securityholder's escrow securities will be
      released from escrow. The Escrow Agent will deliver any share certificates
      or other evidence of the escrow securities in the possession of the Escrow
      Agent to the Securityholder's legal representative.

(2)   Prior to delivery the Escrow Agent must receive:

      (a)   a certified copy of the death certificate; and

      (b)   any evidence of the legal representative's status that the Escrow
            Agent may reasonably require.

                PART 3 EARLY RELEASE ON CHANGE OF ISSUER STATUS

3.1 BECOMING AN ESTABLISHED ISSUER

If the Issuer is an emerging issuer on the date of this Agreement and, during
this Agreement, the Issuer:

      (a)   lists its securities on The Toronto Stock Exchange Inc.;

      (b)   becomes a TSX Venture Exchange Inc. (TSX Venture) Tier 1 issuer; or

      (c)   lists or quotes its securities on an exchange or market outside
            Canada that its "principal regulator" under National Policy 43-201
            Mutual Reliance Review System for Prospectuses and Annual
            Information Forms (in Quebec under Staff Notice, Mutual Reliance
            Review System for Prospectuses and Annual Information Forms) or, if
            the Issuer has only filed its IPO prospectus in one jurisdiction,
            the securities regulator in that jurisdiction, is satisfied has
            minimum listing requirements at least equal to those of TSX Venture
            Tier 1,

then the Issuer becomes an established issuer.

3.2 RELEASE OF ESCROW SECURITIES

(1)   When an emerging issuer becomes an established issuer, the release
      schedule for its escrow securities changes.

(2)   If an emerging issuer becomes an established issuer 18 months or more
      after its listing date, all escrow securities will be released
      immediately.

(3)   If an emerging issuer becomes an established issuer within 18 months after
      its listing date, all escrow securities that would have been released to
      that time, if the Issuer was an established issuer on its listing date,
      will be released immediately. Remaining escrow securities will be released
      in equal installments on the day that is 6 months, 12 months and 18 months
      after the listing date.

3.3 FILING REQUIREMENTS

<PAGE>
                                      -5-

Escrow securities will not be released under this Part until the Issuer does the
following:

      (a)   at least 20 days before the date of the first release of escrow
            securities under the new release schedule, files with the securities
            regulators in the jurisdictions in which it is a reporting issuer

            (i)   a certificate signed by a director or officer of the Issuer
                  authorized to sign stating

                  A.    that the Issuer has become an established issuer by
                        satisfying one of the conditions in section 3.1 and
                        specifying the condition, and

                  B.    the number of escrow securities to be released on the
                        first release date under the new release schedule, and

            (ii)  a copy of a letter or other evidence from the exchange or
                  quotation service confirming that the Issuer has satisfied the
                  condition to become an established issuer; and

      (b)   at least 10 days before the date of the first release of escrow
            securities under the new release schedule, issues and files with the
            securities regulators in the jurisdictions in which it is a
            reporting issuer a news release disclosing details of the first
            release of the escrow securities and the change in the release
            schedule, and sends a copy of such filing to the Escrow Agent.

3.4 AMENDMENT OF RELEASE SCHEDULE

The new release schedule will apply 10 days after the Escrow Agent receives a
certificate signed by a director or officer of the Issuer authorized to sign

      (a)   stating that the Issuer has become an established issuer by
            satisfying one of the conditions in section 3.1 and specifying the
            condition;

      (b)   stating that the release schedule for the Issuer's escrow securities
            has changed;

      (c)   stating that the Issuer has issued a news release at least 10 days
            before the first release date under the new release schedule and
            specifying the date that the news release was issued; and

      (d)   specifying the new release schedule.

                     PART 4 DEALING WITH ESCROW SECURITIES

4.1 RESTRICTION ON TRANSFER, ETC.

Unless it is expressly permitted in this Agreement, you will not sell, transfer,
assign, mortgage, enter into a derivative transaction concerning, or otherwise
deal in any way with your escrow securities or any related share certificates or
other evidence of the escrow securities. If a

<PAGE>
                                      -6-

Securityholder is a private company controlled by one or more principals (as
defined in section 3.5 of the Policy) of the Issuer, the Securityholder may not
participate in a transaction that results in a change of its control or a change
in the economic exposure of the principals to the risks of holding escrow
securities.

4.2 PLEDGE, MORTGAGE OR CHARGE AS COLLATERAL FOR A LOAN

You may pledge, mortgage or charge your escrow securities to a financial
institution as collateral for a loan, provided that no escrow securities or any
share certificates or other evidence of escrow securities will be transferred or
delivered by the Escrow Agent to the financial institution for this purpose. The
loan agreement must provide that the escrow securities will remain in escrow if
the lender realizes on the escrow securities to satisfy the loan.

4.3 VOTING OF ESCROW SECURITIES

You may exercise any voting rights attached to your escrow securities.

4.4 DIVIDENDS ON ESCROW SECURITIES

You may receive a dividend or other distribution on your escrow securities, and
elect the manner of payment from the standard options offered by the Issuer. If
the Escrow Agent receives a dividend or other distribution on your escrow
securities, other than additional escrow securities, the Escrow Agent will pay
the dividend or other distribution to you on receipt.

4.5 EXERCISE OF OTHER RIGHTS ATTACHING TO ESCROW SECURITIES

You may exercise your rights to exchange or convert your escrow securities in
accordance with this Agreement.

                    PART 5 PERMITTED TRANSFERS WITHIN ESCROW

5.1 TRANSFER TO DIRECTORS AND SENIOR OFFICERS

(1)   You may transfer escrow securities within escrow to existing or, upon
      their appointment, incoming directors or senior officers of the Issuer or
      any of its material operating subsidiaries, if the Issuer's board of
      directors has approved the transfer.

(2)   Prior to the transfer the Escrow Agent must receive:

      (a)   a certified copy of the resolution of the board of directors of the
            Issuer approving the transfer;

      (b)   a certificate signed by a director or officer of the Issuer
            authorized to sign, stating that the transfer is to a director or
            senior officer of the Issuer or a material operating subsidiary and
            that any required approval from the Canadian exchange the Issuer is
            listed on has been received;

      (c)   an acknowledgment in the form of Schedule "B" signed by the
            transferee;

<PAGE>
                                      -7-

      (d)   copies of the letters sent to the securities regulators described in
            subsection (3) accompanying the acknowledgement; and

      (e)   a transfer power of attorney, completed and executed by the
            transferor in accordance with the requirements of the Issuer's
            transfer agent.

(3)   At least 10 days prior to the transfer, the Issuer will file a copy of the
      acknowledgement with the securities regulators in the jurisdictions in
      which it is a reporting issuer.

5.2 TRANSFER TO OTHER PRINCIPALS

(1)   You may transfer escrow securities within escrow:

      (a)   to a person or company that before the proposed transfer holds more
            than 20% of the voting rights attached to the Issuer's outstanding
            securities; or

      (b)   to a person or company that after the proposed transfer

            (i)   will hold more than 10% of the voting rights attached to the
                  Issuer's outstanding securities, and

            (ii)  has the right to elect or appoint one or more directors or
                  senior officers of the Issuer or any of its material operating
                  subsidiaries.

(2)   Prior to the transfer the Escrow Agent must receive:

      (a)   a certificate signed by a director or officer of the Issuer
            authorized to sign stating that

            (i)   the transfer is to a person or company that the officer
                  believes, after reasonable investigation, holds more than 20%
                  of the voting rights attached to the Issuer's outstanding
                  securities before the proposed transfer, or

            (ii)  the transfer is to a person or company that

                  A.    the officer believes, after reasonable investigation,
                        will hold more than 10% of the voting rights attached to
                        the Issuer's outstanding securities, and

                  B.    has the right to elect or appoint one or more directors
                        or senior officers of the Issuer or any of its material
                        operating subsidiaries after the proposed transfer, and

            (iii) any required approval from the Canadian exchange the Issuer is
                  listed on has been received;

      (b)   an acknowledgment in the form of Schedule "B" signed by the
            transferee;

<PAGE>
                                      -8-

      (c)   copies of the letters sent to the securities regulators accompanying
            the acknowledgement; and

      (d)   a transfer power of attorney, executed by the transferor in
            accordance with the requirements of the Issuer's transfer agent.

(3)   At least 10 days prior to the transfer, the Issuer will file a copy of the
      acknowledgement with the securities regulators in the jurisdictions in
      which it is a reporting issuer.

5.3 TRANSFER UPON BANKRUPTCY

(1)   You may transfer escrow securities within escrow to a trustee in
      bankruptcy or another person or company entitled to escrow securities on
      bankruptcy.

(2)   Prior to the transfer, the Escrow Agent must receive:

      (a)   a certified copy of either

            (i)   the assignment in bankruptcy filed with the Superintendent of
                  Bankruptcy, or

            (ii)  the receiving order adjudging the Securityholder bankrupt;

      (b)   a certified copy of a certificate of appointment of the trustee in
            bankruptcy;

      (c)   a transfer power of attorney, completed and executed by the
            transferor in accordance with the requirements of the Issuer's
            transfer agent; and

      (d)   an acknowledgment in the form of Schedule "B" signed by:

            (i)   the trustee in bankruptcy, or

            (ii)  on direction from the trustee, with evidence of that
                  direction attached to the acknowledgment form, another person
                  or company legally entitled to the escrow securities.

(3)   Within 10 days after the transfer, the transferee of the escrow securities
      will file a copy of the acknowledgment with the securities regulators in
      the jurisdictions in which the Issuer is a reporting issuer.

5.4 TRANSFER UPON REALIZATION OF PLEDGED, MORTGAGED OR CHARGED ESCROW SECURITIES

(1)   You may transfer within escrow to a financial institution the escrow
      securities you have pledged, mortgaged or charged under section 4.2 to
      that financial institution as collateral for a loan on realization of the
      loan.

(2)   Prior to the transfer the Escrow Agent must receive:

<PAGE>
                                      -9-

      (a)   a statutory declaration of an officer of the financial institution
            that the financial institution is legally entitled to the escrow
            securities;

      (b)   a transfer power of attorney, executed by the transferor in
            accordance with the requirements of the Issuer's transfer agent; and

      (c)   an acknowledgement in the form of Schedule "B" signed by the
            financial institution.

(3)   Within 10 days after the transfer, the transferee of the escrow securities
      will file a copy of the acknowledgment with the securities regulators in
      the jurisdictions in which the Issuer is a reporting issuer.

5.5 TRANSFER TO CERTAIN PLANS AND FUNDS

(1)   You may transfer escrow securities within escrow to or between a
      registered retirement savings plan (RRSP), registered retirement income
      fund (RRIF) or other similar registered plan or fund with a trustee, where
      the annuitant of the RRSP or RRIF, or the beneficiaries of the other
      registered plan or fund are limited to you and your spouse, children and
      parents, or, if you are the trustee of such a registered plan or fund, to
      the annuitant of the RRSP or RRIF, or a beneficiary of the other
      registered plan or fund, as applicable, or his or her spouse, children and
      parents.

(2)   Prior to the transfer the Escrow Agent must receive:

      (a)   evidence from the trustee of the transferee plan or fund, or the
            trustee's agent, stating that, to the best of the trustee's
            knowledge, the annuitant of the RRSP or RRIF, or the beneficiaries
            of the other registered plan or fund do not include any person or
            company other than you and your spouse, children and parents;

      (b)   a transfer power of attorney, executed by the transferor in
            accordance with the requirements of the Issuer's transfer agent; and

      (c)   an acknowledgement in the form of Schedule "B" signed by the trustee
            of the plan or fund.

(3)   Within 10 days after the transfer, the transferee of the escrow securities
      will file a copy of the acknowledgment with the securities regulators in
      the jurisdictions in which the Issuer is a reporting issuer.

5.6 EFFECT OF TRANSFER WITHIN ESCROW

After the transfer of escrow securities within escrow, the escrow securities
will remain in escrow and released from escrow under this Agreement as if no
transfer has occurred on the same terms that applied before the transfer. The
Escrow Agent will not deliver any share certificates or other evidence of the
escrow securities to transferees under this Part 5.

<PAGE>
                                      -10-

                          PART 6 BUSINESS COMBINATIONS

6.1 BUSINESS COMBINATIONS

This Part applies to the following (business combinations):

      (a)   a formal take-over bid for all outstanding equity securities of the
            Issuer or which, if successful, would result in a change of control
            of the Issuer

      (b)   a formal issuer bid for all outstanding equity securities of the
            Issuer

      (c)   a statutory arrangement

      (d)   an amalgamation

      (e)   a merger

      (f)   a reorganization that has an effect similar to an amalgamation or
            merger

6.2 DELIVERY TO ESCROW AGENT

You may tender your escrow securities to a person or company in a business
combination. At least five business days prior to the date the escrow securities
must be tendered under the business combination, you must deliver to the Escrow
Agent:

      (a)   a written direction signed by you that directs the Escrow Agent to
            deliver to the depositary under the business combination any share
            certificates or other evidence of the escrow securities and a
            completed and executed cover letter or similar document and, where
            required, transfer power of attorney completed and executed for
            transfer in accordance with the requirements of the depositary, and
            any other documentation specified or provided by you and required to
            be delivered to the depositary under the business combination; and

      (b)   any other information concerning the business combination as the
            Escrow Agent may reasonably request.

6.3 DELIVERY TO DEPOSITARY

As soon as reasonably practicable, and in any event no later than three business
days after the Escrow Agent receives the documents and information required
under section 6.2, the Escrow Agent will deliver to the depositary, in
accordance with the direction, any share certificates or other evidence of the
escrow securities, and a letter addressed to the depositary that

      (a)   identifies the escrow securities that are being tendered;

      (b)   states that the escrow securities are held in escrow;

<PAGE>
                                      -11-

      (c)   states that the escrow securities are delivered only for the
            purposes of the business combination and that they will be released
            from escrow only after the Escrow Agent receives the information
            described in section 6.4;

      (d)   if any share certificates or other evidence of the escrow securities
            have been delivered to the depositary, requires the depositary to
            return to the Escrow Agent, as soon as practicable, any share
            certificates or other evidence of escrow securities that are not
            released from escrow into the business combination; and

      (e)   where applicable, requires the depositary to deliver or cause to be
            delivered to the Escrow Agent, as soon as practicable, any share
            certificates or other evidence of additional escrow securities that
            you acquire under the business combination.

6.4 RELEASE OF ESCROW SECURITIES BY DEPOSITARY

The Escrow Agent will release from escrow the tendered escrow securities when
the Escrow Agent receives a declaration signed by the depositary or, if the
direction identifies the depositary as acting on behalf of another person or
company in respect of the business combination, by that other person or company,
that:

      (a)   the terms and conditions of the business combination have been met
            or waived; and

      (b)   the escrow securities have either been taken up and paid for or are
            subject to an unconditional obligation to be taken up and paid for
            under the business combination.

6.5 ESCROW OF NEW SECURITIES

If you receive securities (new securities) of another issuer (successor issuer)
in exchange for your escrow securities, the new securities will be subject to
escrow in substitution for the tendered escrow securities if, immediately after
completion of the business combination:

      (a)   the successor issuer is not an exempt issuer (as defined in section
            3.2 of the Policy);

      (b)   you are a principal (as defined in section 3.5 of the Policy) of the
            successor issuer; and

      (c)   you hold more than 1% of the voting rights attached to the successor
            issuer's outstanding securities (In calculating this percentage,
            include securities that may be issued to you under outstanding
            convertible securities in both your securities and the total
            securities outstanding.)

6.6 RELEASE FROM ESCROW OF NEW SECURITIES

(1)   As soon as reasonably practicable after the Escrow Agent receives:

<PAGE>
                                      -12-

      (a)   a certificate from the successor issuer signed by a director or
            officer of the successor issuer authorized to sign

            (i)   stating that it is a successor issuer to the Issuer as a
                  result of a business combination and whether it is an emerging
                  issuer or an established issuer under the Policy, and

            (ii)  listing the Securityholders whose new securities are subject
                  to escrow under section 6.5,

the escrow securities of the Securityholders whose new securities are not
subject to escrow under section 6.5 will be released, and the Escrow Agent will
send any share certificates or other evidence of the escrow securities in the
possession of the Escrow Agent in accordance with section 2.3.

(2)   If your new securities are subject to escrow, unless subsection (3)
      applies, the Escrow Agent will hold your new securities in escrow on the
      same terms and conditions, including release dates, as applied to the
      escrow securities that you exchanged.

(3)   If the Issuer is

      (a)   an emerging issuer, the successor issuer is an established issuer,
            and the business combination occurs 18 months or more after the
            Issuer's listing date, all escrow securities will be released
            immediately; and

      (b)   an emerging issuer, the successor issuer is an established issuer,
            and the business combination occurs within 18 months after the
            Issuer's listing date, all escrow securities that would have been
            released to that time, if the Issuer was an established issuer on
            its listing date, will be released immediately. Remaining escrow
            securities will be released in equal instalments on the day that is
            6 months, 12 months and 18 months after the Issuer's listing date.

                       PART 7 RESIGNATION OF ESCROW AGENT

7.1 RESIGNATION OF ESCROW AGENT

(1)   If the Escrow Agent wishes to resign as escrow agent, the Escrow Agent
      will give written notice to the Issuer.

(2)   If the Issuer wishes to terminate the Escrow Agent as escrow agent, the
      Issuer will give written notice to the Escrow Agent.

(3)   If the Escrow Agent resigns or is terminated, the Issuer will be
      responsible for ensuring that the Escrow Agent is replaced not later than
      the resignation or termination date by another escrow agent that is
      acceptable to the securities regulators having jurisdiction in the matter
      and that has accepted such appointment, which appointment will be binding
      on the Issuer and the Securityholders.

<PAGE>
                                      -13-

(4)   The resignation or termination of the Escrow Agent will be effective, and
      the Escrow Agent will cease to be bound by this Agreement, on the date
      that is 60 days after the date of receipt of the notices referred to above
      by the Escrow Agent or Issuer, as applicable, or on such other date as the
      Escrow Agent and the Issuer may agree upon (the "resignation or
      termination date"), provided that the resignation or termination date will
      not be less than 10 business days before a release date.

(5)   If the Issuer has not appointed a successor escrow agent within 60 days of
      the resignation or termination date, the Escrow Agent will apply, at the
      Issuer's expense, to a court of competent jurisdiction for the appointment
      of a successor escrow agent, and the duties and responsibilities of the
      Escrow Agent will cease immediately upon such appointment.

(6)   On any new appointment under this section, the successor Escrow Agent will
      be vested with the same powers, rights, duties and obligations as if it
      had been originally named herein as Escrow Agent, without any further
      assurance, conveyance, act or deed. The predecessor Escrow Agent, upon
      receipt of payment for any outstanding account for its services and
      expenses then unpaid, will transfer, deliver and pay over to the successor
      Escrow Agent, who will be entitled to receive, all securities, records or
      other property on deposit with the predecessor Escrow Agent in relation to
      this Agreement and the predecessor Escrow Agent will thereupon be
      discharged as Escrow Agent.

(7)   If any changes are made to Part 8 of this Agreement as a result of the
      appointment of the successor Escrow Agent, those changes must not be
      inconsistent with the Policy and the terms of this Agreement and the
      Issuer to this Agreement will file a copy of the new Agreement with the
      securities regulators with jurisdiction over this Agreement and the escrow
      securities.

                     PART 8 OTHER CONTRACTUAL ARRANGEMENTS

8.1 ESCROW AGENT NOT A TRUSTEE

The Escrow Agent accepts duties and responsibilities under this Agreement, and
the escrow securities and any share certificates or other evidence of these
securities, solely as a custodian, bailee and agent. No trust is intended to be,
or is or will be, created hereby and the Escrow Agent shall owe no duties
hereunder as a trustee.

8.2 ESCROW AGENT NOT RESPONSIBLE FOR GENUINENESS

The Escrow Agent will not be responsible or liable in any manner whatever for
the sufficiency, correctness, genuineness or validity of any escrow security
deposited with it.

8.3 ESCROW AGENT NOT RESPONSIBLE FOR FURNISHED INFORMATION

The Escrow Agent will have no responsibility for seeking, obtaining, compiling,
preparing or determining the accuracy of any information or document, including
the representative capacity in which a party purports to act, that the Escrow
Agent receives as a condition to a release from escrow or a transfer of escrow
securities within escrow under this Agreement.

<PAGE>
                                      -14-

8.4 ESCROW AGENT NOT RESPONSIBLE AFTER RELEASE

The Escrow Agent will have no responsibility for escrow securities that it has
released to a Securityholder or at a Securityholder's direction according to
this Agreement.

8.5 INDEMNIFICATION OF ESCROW AGENT

The Issuer and each Securityholder hereby jointly and severally agree to
indemnify and hold harmless the Escrow Agent, its affiliates, and their current
and former directors, officers, employees and agents from and against any and
all claims, demands, losses, penalties, costs, expenses, fees and liabilities,
including, without limitation, legal fees and expenses, directly or indirectly
arising out of, in connection with, or in respect of, this Agreement, except
where same result directly and principally from gross negligence, wilful
misconduct or bad faith on the part of the Escrow Agent. This indemnity survives
the release of the escrow securities, the resignation or termination of the
Escrow Agent and the termination of this Agreement.

8.6 ADDITIONAL PROVISIONS

(1)   The Escrow Agent will be protected in acting and relying reasonably upon
      any notice, direction, instruction, order, certificate, confirmation,
      request, waiver, consent, receipt, statutory declaration or other paper or
      document (collectively referred to as "Documents") furnished to it and
      purportedly signed by any officer or person required to or entitled to
      execute and deliver to the Escrow Agent any such Document in connection
      with this Agreement, not only as to its due execution and the validity and
      effectiveness of its provisions, but also as to the truth or accuracy of
      any information therein contained, which it in good faith believes to be
      genuine.

(2)   The Escrow Agent will not be bound by any notice of a claim or demand with
      respect thereto, or any waiver, modification, amendment, termination or
      rescission of this Agreement unless received by it in writing, and signed
      by the other Parties and approved by the Exchange, and, if the duties or
      indemnification of the Escrow Agent in this Agreement are affected, unless
      it has given its prior written consent.

(3)   The Escrow Agent may consult with or retain such legal counsel and
      advisors as it may reasonably require for the purpose of discharging its
      duties or determining its rights under this Agreement and may rely and act
      upon the advice of such counsel or advisor. The Escrow Agent will give
      written notice to the Issuer as soon as practicable that it has retained
      legal counsel or other advisors. The Issuer will pay or reimburse the
      Escrow Agent for any reasonable fees, expenses and disbursements of such
      counsel or advisors.

(4)   In the event of any disagreement arising under the terms of this
      Agreement, the Escrow Agent will be entitled, at its option, to refuse to
      comply with any and all demands whatsoever until the dispute is settled
      either by a written agreement among the Parties or by a court of competent
      jurisdiction.

(5)   The Escrow Agent will have no duties or responsibilities except as
      expressly provided in this Agreement and will have no duty or
      responsibility under the Policy or arising under

<PAGE>
                                      -15-

      any other agreement, including any agreement referred to in this
      Agreement, to which the Escrow Agent is not a party.

(6)   The Escrow Agent will have the right not to act and will not be liable for
      refusing to act unless it has received clear and reasonable documentation
      that complies with the terms of this Agreement. Such documentation must
      not require the exercise of any discretion or independent judgment.

(7)   The Escrow Agent is authorized to cancel any share certificate delivered
      to it and hold such Securityholder's escrow securities in electronic, or
      uncertificated form only, pending release of such securities from escrow.

(8)   The Escrow Agent will have no responsibility with respect to any escrow
      securities in respect of which no share certificate or other evidence or
      electronic or uncertificated form of these securities has been delivered
      to it, or otherwise received by it.

8.7 LIMITATION OF LIABILITY OF ESCROW AGENT

The Escrow Agent will not be liable to any of the Parties hereunder for any
action taken or omitted to be taken by it under or in connection with this
Agreement, except for losses directly, principally and immediately caused by its
bad faith, wilful misconduct or gross negligence. Under no circumstances will
the Escrow Agent be liable for any special, indirect, incidental, consequential,
exemplary, aggravated or punitive losses or damages hereunder, including any
loss of profits, whether foreseeable or unforeseeable. Notwithstanding the
foregoing or any other provision of this Agreement, in no event will the
collective liability of the Escrow Agent under or in connection with this
Agreement to any one or more Parties, except for losses directly caused by its
bad faith or wilful misconduct, exceed the amount of its annual fees under this
Agreement or the amount of three thousand dollars ($3,000.00), whichever amount
shall be greater.

8.8 REMUNERATION OF ESCROW AGENT

The Issuer will pay the Escrow Agent reasonable remuneration for its services
under this Agreement, which fees are subject to revision from time to time on 30
days' written notice. The Issuer will reimburse the Escrow Agent for its
expenses and disbursements. Any amount due under this section and unpaid 30 days
after request for such payment, will bear interest from the expiration of such
period at a rate per annum equal to the then current rate charged by the Escrow
Agent, payable on demand.

8.9 INDEMNIFICATION OF THE EXCHANGE

(1)   The Issuer and each Securityholder jointly and severally:

      (a)   release, indemnify and save harmless the Exchange from all costs
            (including legal cost, expenses and disbursements), charges, claims,
            demands, damages, liabilities, losses and expenses incurred by the
            Exchange;

<PAGE>
                                      -16-

      (b)   agree not to make or bring a claim or demand, or commence any
            action, against the Exchange; and

      (c)   agree to indemnify and save harmless the Exchange from all costs
            (including legal costs) and damages that the Exchange incurs or is
            required by law to pay as a result of any person's claim, demand or
            action,

arising from any and every act or omission committed or omitted by the Exchange,
in connection with this Agreement, even if said act or omission was negligent,
or constituted a breach of the terms of this Agreement.

(2)   This indemnity survives the release of the escrow securities and the
      termination of this Agreement.

                                 PART 9 NOTICES

9.1 NOTICE TO ESCROW AGENT

Documents will be considered to have been delivered to the Escrow Agent on the
next business day following the date of transmission, if delivered by fax, the
date of delivery, if delivered by hand during normal business hours or by
prepaid courier, or 5 business days after the date of mailing, if delivered by
mail, to the following:

         Pacific Corporate Trust Company
         625 Howe Street, 10th Floor
         Vancouver, BC V6C 3B8

         Attention: -

         Fax: (604) - 689-8144

9.2 NOTICE TO ISSUER

Documents will be considered to have been delivered to the Issuer on the next
business day following the date of transmission, if delivered by fax, the date
of delivery, if delivered by hand during normal business hours or by prepaid
courier, or 5 business days after the date of mailing, if delivered by mail, to
the following:

         Chemokine Therapeutics Corp.
         2386 East Mall
         Suite 208, University of British Columbia
         Vancouver, British Columbia V6T 1Z3

         Attention: Hassan Salari
         Fax: - (604) 822-0302

With a copy to:

         Thomas, Rondeau

<PAGE>
                                      -17-

         Suite 1525 - 625 Howe Street
         Vancouver, British Columbia, V6C 2T6

         Attention: Craig D. Thomas
         Fax: (604) 688-6995

9.3 DELIVERIES TO SECURITYHOLDERS

Documents will be considered to have been delivered to a Securityholder on the
date of delivery, if delivered by hand or by prepaid courier, or 5 business days
after the date of mailing, if delivered by mail, to the address on the Issuer's
share register.

Any share certificates or other evidence of a Securityholder's escrow securities
will be sent to the Securityholder's address on the Issuer's share register
unless the Securityholder has advised the Escrow Agent in writing otherwise at
least ten business days before the escrow securities are released from escrow.
The Issuer will provide the Escrow Agent with each Securityholder's address as
listed on the Issuer's share register.

 9.4 CHANGE OF ADDRESS

(1)   The Escrow Agent may change its address for delivery by delivering notice
      of the change of address to the Issuer and to each Securityholder.

(2)   The Issuer may change its address for delivery by delivering notice of the
      change of address to the Escrow Agent and to each Securityholder.

(3)   A Securityholder may change that Securityholder's address for delivery by
      delivering notice of the change of address to the Issuer and to the Escrow
      Agent.

9.5 POSTAL INTERRUPTION

A Party to this Agreement will not mail a document it is required to mail under
this Agreement if the Party is aware of an actual or impending disruption of
postal service.

                                PART 10 GENERAL

10.1  INTERPRETATION - "HOLDING SECURITIES"

When this Agreement refers to securities that a Securityholder "holds", it means
that the Securityholder has direct or indirect beneficial ownership of, or
control or direction over, the securities.

10.2 FURTHER ASSURANCES

The Parties will execute and deliver any further documents and perform any
further acts reasonably requested by any of the Parties to this Agreement which
are necessary to carry out the intent of this Agreement.

<PAGE>
                                      -18-

10.3 TIME

Time is of the essence of this Agreement.

10.4 INCOMPLETE IPO

If the Issuer does not complete its IPO and has become a reporting issuer in one
or more jurisdictions because it has obtained a receipt for its IPO prospectus,
this Agreement will remain in effect until the securities regulators in those
jurisdictions order that the Issuer has ceased to be a reporting issuer.

10.5 GOVERNING LAW

The laws of British Columbia (the "Principal Regulator") and the applicable laws
of Canada will govern this Agreement.

10.6 JURISDICTION

The securities regulator in each jurisdiction where the Issuer files its IPO
prospectus has jurisdiction over this Agreement and the escrow securities.

10.7 CONSENT OF SECURITIES REGULATORS TO AMENDMENT

Except for amendments made under Part 3, the securities regulators with
jurisdiction must approve any amendment to this Agreement and will apply mutual
reliance principles in reviewing any amendments that are filed with them.
Therefore, the consent of the Principal Regulator will evidence the consent of
all securities regulators with jurisdiction.

10.8 COUNTERPARTS

The Parties may execute this Agreement by fax and in counterparts, each of which
will be considered an original and all of which will be one agreement.

10.9 SINGULAR AND PLURAL

Wherever a singular expression is used in this Agreement, that expression is
considered as including the plural or the body corporate where required by the
context.

10.10 LANGUAGE

This Agreement has been drawn up in the English language at the request of all
Parties. Cette convention a ete redige en anglais a la demande de toutes les
Parties.

10.11 BENEFIT AND BINDING EFFECT

This Agreement will benefit and bind the Parties and their heirs, executors,
administrators, successors and permitted assigns and all persons claiming
through them as if they had been a Party to this Agreement.

<PAGE>
                                      -19-

10.12 ENTIRE AGREEMENT

This is the entire agreement among the Parties concerning the subject matter set
out in this Agreement and supersedes any and all prior understandings and
agreements.

10.13 SUCCESSOR TO ESCROW AGENT

Any corporation with which the Escrow Agent may be amalgamated, merged or
consolidated, or any corporation succeeding to the business of the Escrow Agent
will be the successor of the Escrow Agent under this Agreement without any
further act on its part or on the part or any of the Parties, provided that the
successor is recognized as a transfer agent by the Canadian exchange the Issuer
is listed on (or if the Issuer is not listed on a Canadian exchange, by any
Canadian exchange) and notice is given to the securities regulators with
jurisdiction.

                                    EXECUTION

IN WITNESS WHEREOF the parties hereto have caused this Agreement to be duly
executed and delivered as of the day and year first above written.

                  CHEMOKINE THERAPEUTICS CORP.

                  by:  /s/ Hassan Salari
                       -----------------------------------------

                  and:                                               c/s
                       -----------------------------------------

                  PACIFIC CORPORATE TRUST COMPANY

                  by:  /s/ Marc Castonguay
                       -----------------------------------------

                  and: /s/ Norm Hamade                               c/s
                       -----------------------------------------

                  PACIFIC MEDICAL CORP.

                  by:  /s/ Hassan Salari
                       -----------------------------------------

                  and:                                               c/s
                       -----------------------------------------

<PAGE>
                                  SCHEDULE "A"
                                 SECURITYHOLDER

NAME:             PACIFIC MEDICAL CORP
<Table>
<Caption>
SECURITIES:

--------------------------------------------------------------------------------
<S>                           <C>                <C>
CLASS OR DESCRIPTION          NUMBER             CERTIFICATE(S) (IF APPLICABLE)

--------------------------------------------------------------------------------
common shares                 6,247,101
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
</Table>

<PAGE>

                                  SCHEDULE "B"

                    ACKNOWLEDGMENT AND AGREEMENT TO BE BOUND

I acknowledge that the securities listed in the attached Schedule "A" (the
"escrow securities") have been or will be transferred to me and that the escrow
securities are subject to an Escrow Agreement dated __________________________
(the "Escrow Agreement").

For other good and valuable consideration, I agree to be bound by the Escrow
Agreement in respect of the escrow securities, as if I were an original
signatory to the Escrow Agreement.

Dated at ____________________ on ______________.

Where the transferee is an individual:

Signed, sealed and delivered by             )
[TRANSFEREE] in the presence of:            )
                                            )
--------------------------------------      )
Signature of Witness                        )
                                            )   ---------------------------
                                            )        [TRANSFEREE]
--------------------------------------      )
Name of Witness                             )
                                            )

Where the transferee is not an individual:

[TRANSFEREE]

-----------------------------------------
Authorized signatory

-----------------------------------------
Authorized signatory<PAGE>
                                                                   Exhibit 10.17

THE WARRANTS AND THE COMMON SHARES DELIVERABLE UPON EXERCISE THEREOF HAVE NOT
BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "U.S.
SECURITIES ACT") OR UNDER ANY STATE SECURITIES LAWS. THESE WARRANTS AND THE
UNDERLYING COMMON SHARES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO
U.S. PERSONS UNLESS THESE WARRANTS AND THE UNDERLYING COMMON SHARES ARE
REGISTERED UNDER THE U.S. SECURITIES ACT, OR AN EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE U.S. SECURITIES ACT IS AVAILABLE. HEDGING TRANSACTIONS
INVOLVING THESE WARRANTS AND THE UNDERLYING COMMON SHARES MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE U.S. SECURITIES ACT. THE HOLDER HEREOF, AGREES FOR
THE BENEFIT OF THE CORPORATION THAT THESE WARRANTS AND THE UNDERLYING COMMON
SHARES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE
CORPORATION, (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE U.S.
SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER OR ANOTHER APPLICABLE EXEMPTION,
OR (C) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT. DELIVERY OF THIS
CERTIFICATE MAY NOT CONSTITUTE "GOOD DELIVERY" IN SETTLEMENT OF TRANSACTIONS ON
STOCK EXCHANGES IN CANADA.

THIS WARRANT MAY NOT BE EXERCISED ON BEHALF OF ANY U.S. PERSON UNLESS REGISTERED
UNDER THE U.S. SECURITIES ACT OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST
NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER THE
LATER OF (i) _____________, AND (II) THE DATE THE ISSUER BECAME A REPORTING
ISSUER IN ANY PROVINCE OR TERRITORY.

ANY SHARE CERTIFICATE ISSUED PURSUANT TO AN EXERCISE OF THESE WARRANTS BEFORE
THE LATER OF (i) ____________, AND (II) THE DATE THE ISSUER BECAME A REPORTING
ISSUER IN ANY PROVINCE OR TERRITORY MUST CONTAIN THE FOLLOWING LEGEND:

         "UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS
         SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
         AND A DAY AFTER THE LATER OF (i) ________, AND (II) THE DATE THE ISSUER
         BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY."

THE WARRANTS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE UNLESS EXERCISED
WITHIN THE TIME LIMIT HEREIN PROVIDED.

                 AGENT'S NON-TRANSFERABLE SHARE PURCHASE WARRANT

                          CHEMOKINE THERAPEUTICS CORP.
             (Incorporated under the laws of the State of Delaware)

No. 2004/_______               Representing _______ Share Purchase Warrants (the
                               "Warrants") entitling the Agent to purchase
                               _______ common shares, $0.001 par value.

THIS IS TO CERTIFY that, for value received, CANACCORD CAPITAL CORPORATION (the
"Agent"), of #2200 - 609 Granville Street, Vancouver, BC, V7Y 1H2,

<PAGE>

has the right to purchase from CHEMOKINE THERAPEUTICS CORP. (the "Company"),
upon and subject to the terms and conditions hereinafter referred to _______
fully paid and non-assessable common shares of the Company (the "Shares") at the
price of $____ per Share if exercised at any time until 4:30 p.m. (Vancouver
time) on _______, 2006 (the "Expiry Time").

THE FOLLOWING ARE THE TERMS AND CONDITIONS OF THE WARRANTS:

1.   The right to purchase Shares granted by this Warrant Certificate may only
     be exercised by the Agent within the times set out above by:

     (a)  completing and executing the Exercise Form attached to this Warrant
          Certificate in the manner indicated;

     (b)  surrendering this Warrant Certificate to Chemokine Therapeutics Corp.
          c/o Thomas, Rondeau, Suite 1525 - 625 Howe Street, Vancouver, B.C.,
          V6C 2T6; and

     (c)  paying the appropriate purchase price for the Shares subscribed for
          either by cash, certified cheque or bank draft payable at par in
          Vancouver, British Columbia.

2.   Upon surrender of this Warrant Certificate and receipt of payment, the
     Company will issue to the Agent the appropriate number of Shares issuable
     in accordance with the terms and conditions of this Warrant Certificate not
     exceeding those which the Agent is entitled to at the time of exercise. If
     the Agent exercises a portion of the Warrants represented by this Warrant
     Certificate, he or she will be entitled to receive, without charge, a new
     Warrant Certificate representing the unexercised portion of the Warrants
     represented herein.

3.   After the full or partial exercise by the Agent, the Company will cause to
     be mailed or delivered certificate(s) for the number of Shares issuable to
     the Agent within three business days at the address specified in the
     register of warrantholders maintained by the Company.

4.   The right to purchase Shares represented hereby has been issued by the
     Company in reliance upon the prospectus exemptions contained in applicable
     securities legislation. Consequently, any resale of the Shares by the Agent
     are subject to any applicable resale restrictions contained in such
     legislation.

5.   The Agent hereby agrees to comply with all applicable securities
     legislation in connection with the holding of the Warrants and the holding
     and exercise of the Shares issuable upon exercise of the Warrants.

6.   The Warrants evidenced by this Warrant Certificate are not transferable
     except where a person furnishes evidence that he is, to the reasonable
     satisfaction of the Company, a liquidator or, or a trustee in bankruptcy
     for, the Agent and surrenders such evidence together with the Warrant
     Certificate in question to the Company (by delivery or mail as set forth
     herein), and such further reasonable requirements as the Company and all
     applicable securities regulatory authorities may prescribe at which time
     such person will become noted upon the register of warrantholders. After
     receiving the surrendered

                                      -2-

<PAGE>

     Warrant Certificate and upon the Agent surrendering the Warrant Certificate
     meeting the requirements as hereinbefore set forth, the Company shall
     forthwith cause a new Warrant Certificate to be issued and sent to the new
     holder and the Company shall alter the register of warrantholders
     accordingly.

7.   Subject to the provisions of this Warrant Certificate and applicable law,
     the Agent is entitled to the rights and privileges attaching to the
     Warrants, and the issue of the Shares by the Company on exercise of
     Warrants by the Agent in accordance with the terms and conditions herein
     contained discharges all responsibilities of the Company with respect to
     such Warrants and the Company is not bound to inquire into the title of any
     such registered holder.

8.   Nothing in this Warrant Certificate or in the holding of Warrants evidenced
     by this Warrant Certificate, or otherwise, shall be construed as conferring
     upon the Agent any right or interest whatsoever as a shareholder, including
     but not limited to the right to vote at, to receive notice of, or to attend
     meetings of shareholders or any other proceedings of the Company or the
     right to receive any dividend and other distribution except as otherwise
     provided herein.

9.   The Company hereby covenants and agrees as follows:

     (a)  all Shares which may be issued upon exercise of this Warrant
          Certificate, in accordance with the respective terms thereof, will be
          validly issued, fully paid and non-assessable and free from any and
          all taxes, liens and charges with respect to the issue thereof (other
          than taxes in respect of any transfer occurring contemporaneously with
          such issue); and

     (b)  during the period within which the Warrants may be exercised, the
          Company will at all times have authorized and reserved a sufficient
          number of Shares to provide for the respective exercise of the
          Warrants.

10.  All Warrants in this series shall rank pari passu, notwithstanding the
     actual date of issue thereof.

11.  The Agent may at any time up to the Expiry Time, upon written instruction
     delivered to the Company and payment of applicable charges, exchange this
     Warrant Certificate for other Warrant Certificates evidencing Warrants
     entitling the Agent to acquire in the aggregate the same number of Shares
     as may be acquired under this Warrant Certificate.

12.  If any time after the date hereof and prior to the Expiry Time, and
     provided that any Warrants remain unexercised, there shall be:

     (a)  a reclassification of the Shares outstanding at the time or a change
          in the Shares into other shares or securities or a subdivision or
          consolidation of the Shares into a greater or lesser number of Shares,
          or any other capital reorganization; or

     (b)  a consolidation, amalgamation or merger of the Company with or into
          any other Company (other than a consolidation, amalgamation or merger
          which does not result in any reclassification of the outstanding
          common shares or a change of the common shares into other share or
          securities),

                                      -3-
<PAGE>

     (any of such events being call a "Capital Reorganization"), the Agent which
     thereafter shall exercise or be deemed to have exercised its right to
     acquire the Shares pursuant to this Warrant Certificate shall be entitled
     to receive, at no additional cost, and shall accept in lieu of the number
     of the Shares to which the Agent was theretofore entitled upon such
     exercise, the aggregate number of shares, warrants, other securities or
     other property which the Agent should have been entitled to receive as a
     result of such Capital Reorganization if, on the effective date or record
     date thereof as the case may be, the Agent had been the registered
     shareholder of the number of the Shares to which the Agent was theretofore
     entitled to acquire upon exercise or deemed exercise of this Warrant
     Certificate. If determined appropriate by the Company acting reasonably,
     appropriate adjustments shall be made as a result of any such Capital
     Reorganization in the application of the provisions set forth herein with
     respect to the rights and interests thereafter of the Agent to the end that
     the provisions set forth herein shall thereafter correspondingly be made
     applicable as nearly as may reasonably be in relation to any warrants,
     other securities or other property thereafter deliverable upon the exercise
     of any Warrants. Any such adjustment shall be made by and approved by the
     directors and shall for all purposes be conclusively deemed to be an
     appropriate adjustment.

13.  The adjustments provided for herein are cumulative and such adjustments
     shall be made successively whenever an event referred to herein shall
     occur, subject to the limitations provided for herein.

14.  No adjustments shall be made in the number or kind of Shares or other
     securities which may be acquired on the exercise of a Warrant unless it
     would result in a change of at least one-hundredth of a Share (provided,
     however, that any adjustments which may by reason of this paragraph not be
     required to be made, shall be carried forward and then taken into
     consideration in any subsequent adjustment).

15.  No adjustment shall be made in respect of any event described herein, if
     the Agent is entitled to participate in such event on the same terms,
     without amendment, as if the Agent had exercised his or her Warrants prior
     to or on the effective date or record date of such event.

16.  In the event of any question arising with respect to any adjustment
     provided for herein, such question shall be conclusively determined by a
     firm of chartered accountants appointed by the Company at its sole
     discretion (which may be the Company's auditors) and any such determination
     shall be binding upon the Company and the Agent.

17.  As a condition precedent to the taking of any action which would require
     any adjustments in any of the subscription rights pursuant to any of the
     Warrants, the Company shall take any corporate action which may, in the
     opinion of counsel of the Company, be necessary in order that the Company
     have unissued and reserved in its authorized capital and may validly and
     legally issue as fully paid and non-assessable all the securities which the
     Agent is entitled to receive on the exercise of all the subscription rights
     attaching thereto in accordance with the provisions thereof.

18.  In case the Company, after the date hereof, shall take any action affecting
     any securities of the Company, other than as previously set out herein,
     which in the opinion of the

                                      -4-
<PAGE>

     directors of the Company would materially affect the rights of the Agent,
     the number of Shares which shall be issuable on the exercise or deemed
     exercise of the Warrants shall be adjusted in such manner, if any, and at
     such time, as the directors, in their sole discretion, may determine to be
     equitable in the circumstances provided that no such adjustment will be
     made unless all necessary regulatory approvals, if any, have been obtained.
     Failure of the taking of action by the directors so as to provide for such
     an adjustment prior to the effective date of any action by the Company
     affecting any securities of the Company shall be evidence that the
     directors have determined that it is equitable to make no adjustments in
     the circumstances.

19.  Notwithstanding any adjustments provided for herein or otherwise, the
     Company shall not be required upon the exercise of any Warrants, to issue
     fractional Shares in satisfaction of its obligations hereunder and except
     as provided for herein, any fractions shall be eliminated. To the extent
     that the Agent would otherwise be entitled to acquire a fraction of a
     Share, such right may be exercised in respect of such fraction only in
     combination with other rights which in the aggregate entitle the Agent to
     acquire a whole number of Shares.

20.  In any situation where an event occurs which results in an increase in the
     number of Shares which may be issuable on the exercise or deemed exercise
     of the Warrants taking effect immediately after the record date for a
     specific event, if any Warrant is exercised after that record date and
     prior to completion of the event, the Company may postpone the issuance, to
     the Agent, of the Shares to which the Agent is entitled by reason of such
     adjustment, but such Shares shall be so issued and delivered to the Agent
     upon completion of that event, with the number of such Shares calculated on
     the basis of the number of Shares provided for after the adjustment
     provided for herein on the date of exercise of the Warrants adjusted for
     completion of that event and the Company shall deliver to the Agent an
     appropriate instrument evidencing the right of the Agent to receive such
     Shares and the right to receive any dividends or other distributions which,
     but for the provisions of this paragraph, such person or persons would have
     been entitled to receive in respect of such securities from and after the
     date that the Warrants were exercised in respect thereof.

21.  In case this Warrant Certificate shall become mutilated or be lost,
     destroyed or stolen, the Company, subject to applicable law, shall issue
     and deliver a new Warrant Certificate representing the Warrants of like
     date and tenor as the one mutilated, lost, destroyed or stolen upon
     surrender of and in place of and upon cancellation of the mutilated Warrant
     Certificate or in lieu of and in substitution for the lost, destroyed or
     stolen Warrant Certificate. The applicant for the issue of a new Warrant
     Certificate representing the Warrants pursuant to this section shall bear
     the cost of the issue thereof and in case of loss, destruction or theft
     shall, as a condition precedent to the issue thereof, furnish to the
     Company such evidence of ownership and of the loss, destruction or theft of
     the Warrant Certificate so lost, destroyed or stolen as shall be
     satisfactory to the Company and in its discretion and the applicant may
     also be required to furnish an indemnity in amount and form satisfactory to
     the Company in its discretion, and shall pay the reasonable charges of the
     Company in connection therewith.

                                      -5-

<PAGE>

22.  Any notice or delivery or surrender of documents shall be valid and
     effective if delivered personally or if sent by registered letter, postage
     prepaid, or if electronically transmitted by facsimile transmission tested
     for reception prior to use, addressed to:

     (a)  Chemokine Therapeutics Corp., c/o Thomas Rondeau, Suite 1525 - 625
          Howe Street, Vancouver, British Columbia, V6C 2T6, facsimile number
          (604) 688-6995; and

     (b)  to the Warrantholder at the address indicated on the first page,

     and shall be deemed to have been effectively given, received and made on
     the date of personal delivery or on the fourth Business Day after the time
     of mailing or upon actual receipt, whichever is sooner, or upon the day,
     other than Saturday, Sunday or a statutory holiday, after the time of
     facsimile transmission. In the case of disruption in postal services any
     notice, if mailed, shall not be deemed to have been effectively given until
     it is personally delivered. The Company or the Agent may from time to time
     notify the other in writing of a change of address.

23.  The Warrants represented by this certificate may be exercised in whole or
     in part from time to time, and this certificate may be exchanged, upon its
     surrender to the Company, for new Warrant Certificates of like tenor in
     denominations which represent in the aggregate the right to subscribe for
     and receive the number of Shares which may be subscribed for hereunder. If
     the Warrants represented by this certificate are exercised in part, the
     Company shall deliver with the Shares acquired on such exercise, a new
     Warrant Certificate representing the balance of the Warrants remaining
     unexercised.

24.  Unless the Warrants and Shares are registered under the U.S. Securities
     Act, the Agent exercising a Warrant shall be required to give (A) written
     certification that the Agent is not a U.S. person and the Warrant is not
     being exercised on behalf of a U.S. person; or (B) a written opinion of
     counsel to the effect that the Warrant and the securities delivered upon
     exercise thereof have been registered under the U.S. Securities Act or are
     exempt from registration thereunder. Further the Company may implement
     procedures to ensure that the Warrant may not be exercised within the
     United States, and that the Shares may not be delivered within the United
     States upon exercise, other than in offerings deemed to meet the definition
     of "offshore transaction" pursuant to Regulation S Section 230.902(h),
     unless registered under the U.S. Securities Act or an exemption from such
     registration is available.

25.  The Warrants and the Shares are deemed to be "restricted securities" as
     defined in SEC Rule Section 230.144. Resales of any of such restricted
     Warrants and Shares by a non-U.S. Person must be made in accordance with
     SEC Regulation S, the registration requirements of the U.S. Securities Act
     or an exemption therefrom. The Warrants and the Shares will continue to be
     deemed to be restricted securities, notwithstanding that they were acquired
     in a resale transaction made pursuant to SEC Regulation S Section 230.901
     or Section 230.904.

26.  Unless the Warrants and Shares are registered under the U.S. Securities
     Act, the offer or sale of the Warrant or the Shares by the Warrantholder,
     if made prior to the expiration of a one-year distribution compliance
     period (as defined in SEC Regulation S), is not made to a U.S. person or
     for the account or benefit of a U.S. person; and the offer or sale of the

                                      -6-
<PAGE>

     Warrant or the Shares by the Warrantholder, if made prior to the expiration
     of a one-year distribution compliance period (as defined in SEC Regulation
     S), is made pursuant to the following conditions: (1) The purchaser of the
     Warrant or the Shares certifies that it is not a U.S. person and is not
     acquiring the Warrant or the Shares for the account or benefit of any U.S.
     person or is a U.S. person who purchased the Warrant or the Shares in a
     transaction that did not require registration under the Act. (2) The
     purchaser of the Warrant or the Shares agrees to resell such securities
     only in accordance with the provisions of SEC Regulation S, pursuant to
     registration under the U.S. Securities Act, or pursuant to an available
     exemption from registration; and agrees not to engage in hedging
     transactions with regard to the Warrant or the Shares unless in compliance
     with the U.S. Securities Act

27.  Time shall be of the essence hereof.

28.  After the exercise of any of the Warrants represented by this Warrant
     Certificate, the Agent shall no longer have any rights under this Warrant
     Certificate with respect to such Warrants, other than the right to receive
     certificates representing the Shares issuable on the exercise of those
     Warrants, and those Warrants shall be void and of no further value or
     effect.

29.  This Warrant Certificate shall be construed in accordance with the laws of
     the Province of British Columbia and the laws of Canada applicable herein
     and shall be treated in all respects as a British Columbia contract.

IN WITNESS WHEREOF the Company has caused this Special Warrant certificate to be
signed by its duly authorized officer as of the ____ day of December, 2004.

CHEMOKINE THERAPEUTICS CORP.

Per:
          ---------------------------------------
          Authorized Signing Officer

Share Purchase Warrant No. 2004/___________

                                      -7-
<PAGE>

                                  EXERCISE FORM

TO:               CHEMOKINE THERAPEUTICS CORP.
                  c/o Thomas, Rondeau
                  Suite 1525 - 625 Howe Street
                  Vancouver, B.C.  V6C 2T6
--------------------------------------------------------------------------------

THE UNDERSIGNED Agent hereby exercises the right to acquire _____________ common
shares of CHEMOKINE THERAPEUTICS CORP., on the terms specified in the Warrant
Certificate.

The undersigned hereby directs that the said Shares be issued as follows:

<TABLE>
<CAPTION>

       NAME(S) IN FULL                    ADDRESS(ES)                          NUMBER OF SHARES
       ---------------                    -----------                          ----------------

<S>                             <C>                                <C>
-------------------------------  ---------------------------------  --------------------------------------

-------------------------------  ---------------------------------  --------------------------------------

</TABLE>

[Please print. If securities are issued to a person other than Agent, the Agent
must pay to the Company all eligible taxes and other duties and the signature of
the Agent must be guaranteed.]

DATED this ____ day of _____________________, ________________ .

----------------------------------       ----------------------------------
Signature Witnessed or                   (Signature of Agent to be the same
Guaranteed (See instructions             as appears on the face of this
to Agents below)                         Warrant Certificate)

Name of Agent:          ------------------------------------------------------

Address (PLEASE PRINT): ------------------------------------------------------

                        ------------------------------------------------------

Unless the Warrants and Shares are registered under the U.S. Securities Act the
Agent exercising a Warrant shall provide the following certification or include
an opinion of counsel to the effect that the Warrant and the securities
delivered upon exercise thereof have been registered under the U.S. Securities
Act or are exempt from registration thereunder.

The undersigned Agent hereby certifies that Agent is not a U.S. Person (as
defined in Regulation S under the U.S. Securities Act of 1933) and the Warrant
is not being exercised on behalf of a U.S. Person

                                            ---------------------------------
                                            (Signature of Agent)

<PAGE>

                              INSTRUCTIONS TO AGENT

TO EXERCISE:

If the Agent exercises Warrants prior to the Expiry Time pursuant to this
Warrant Certificate, it must deliver the Warrant Certificate and complete, sign
and deliver the Exercise Form to the Company indicating the number of Shares to
be acquired. In such case, the signature of such registered holder on the
Exercise Form must be witnessed or guaranteed, as the case may be.

If this exercise form indicates that the common shares and warrants are to be
issued to a person or persons other than the registered holder of this Warrant
Certificate, the signature of such holder on the exercise form must be
guaranteed by an authorized officer of a chartered bank, trust company or
Medallion Guaranteed by an investment dealer who is a member of a recognized
stock exchange.

GENERAL:

If the Exercise Form is signed by an officer of a corporation or any person
acting in a fiduciary or representative capacity, the Warrant Certificate must
also be accompanied by evidence of authority to sign satisfactory to the
Company.

The name and address of the Company is:

                          CHEMOKINE THERAPEUTICS CORP.
                               c/o Thomas, Rondeau
                          Suite 1525 - 625 Howe Street
                                 Vancouver, B.C.
                                     V6C 2T6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]